Compare BBDO & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBDO | CNC |
|---|---|---|
| Founded | 1943 | 1984 |
| Country | Brazil | United States |
| Employees | 80348 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7B | 32.1B |
| IPO Year | N/A | 2001 |
| Metric | BBDO | CNC |
|---|---|---|
| Price | $2.99 | $63.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $46.75 |
| AVG Volume (30 Days) | 81.7K | ★ 3.6M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $70.86 | $8.31 |
| Revenue Next Year | $8.33 | $1.05 |
| P/E Ratio | ★ $9.20 | $21.01 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $2.37 | $25.08 |
| 52 Week High | $3.80 | $66.55 |
| Indicator | BBDO | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 64.70 |
| Support Level | $2.86 | $33.00 |
| Resistance Level | $3.04 | N/A |
| Average True Range (ATR) | 0.11 | 2.07 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 32.25 | 68.71 |
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.